Non‐alcoholic fatty liver disease
- 9 April 2003
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 17 (8), 977-986
- https://doi.org/10.1046/j.1365-2036.2003.01493.x
Abstract
Non-alcoholic fatty liver disease is a clinicopathological condition that comprises a wide spectrum of liver damage, ranging from simple steatosis to steatohepatitis, advanced fibrosis and cirrhosis. Non-alcoholic steatohepatitis represents only a stage within the spectrum of non-alcoholic fatty liver disease and is defined pathologically by the presence of steatosis together with necro-inflammatory activity. The true prevalence of non-alcoholic fatty liver disease is unknown, but it is estimated that it affects 10-24% of the general population in different countries. The diagnosis of non-alcoholic fatty liver disease is based upon convincing evidence of absent or minimal alcohol consumption, compatible histological changes in liver biopsy and the exclusion of other liver diseases. The natural history of non-alcoholic fatty liver disease remains to be defined. Patients with pure steatosis on liver biopsy follow a relatively benign course, whereas patients with histological necro-inflammatory changes and/or fibrosis may progress to end-stage liver disease. An initial step in the treatment of non-alcoholic fatty liver disease is the management of associated conditions, such as obesity, diabetes mellitus and hyperlipidaemia. Non-alcoholic fatty liver disease patients with steatohepatitis and/or fibrosis on liver biopsy may benefit from investigational pharmacological therapy. Patients with decompensated cirrhosis from non-alcoholic fatty liver disease may be candidates for liver transplantation.Keywords
This publication has 73 references indexed in Scilit:
- Serum markers of liver fibrosis in patients with Non-Alcoholic Steatohepatitis (NASH). Correlation to liver morphology and effect of therapyJournal of Hepatology, 2000
- Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot studyThe Journal of Pediatrics, 2000
- Phlebotomy reduces transaminase levels in patients with non-alcholic steatohepatitisGastroenterology, 2000
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆Gastroenterology, 1999
- Appetite-Suppressant Drugs and the Risk of Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in miceJournal of Hepatology, 1996
- Persistent hyperaminotransferasemia resolving after weight reduction in obese childrenThe Journal of Pediatrics, 1994
- Hepatic effects of dietary weight loss in morbidly obese subjectsJournal of Hepatology, 1991
- Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factorsHepatology, 1990
- Intestinal bypass surgery for morbid obesity. Long-term resultsPublished by American Medical Association (AMA) ,1976